Press Releases from DelveInsight Business Research (5618 total)
Waldenstrom Macroglobulinemia Treatment Market 2034: Clinical Trials, Medication …
(Albany, USA) DelveInsight's "Waldenstrom Macroglobulinemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Waldenstrom Macroglobulinemia, historical and forecasted epidemiology as…
Indolent Lymphoma Market Forecast 2032: Clinical Trials, Epidemiology Trends, FD …
(Albany, USA) DelveInsight's "Indolent Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Indolent Lymphoma, historical and forecasted epidemiology as well…
Bipolar Depression Market Growth to Accelerate in Forecast Period (2024-2034), D …
DelveInsight's "Bipolar Depression Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bipolar Depression, historical and forecasted epidemiology as well as…
Fanconi Anemia Market to Expand Significantly by 2034, States DelveInsight Repor …
DelveInsight's "Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fanconi Anemia, historical and forecasted epidemiology as well as…
Vascular Ehlers-Danlos Syndrome Market Growth Projections 2023-2032: DelveInsigh …
The Vascular Ehlers-Danlos Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Acute Kidney Injury Market on Track for Major Expansion by 2034, According to De …
DelveInsight's "Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Acute Kidney Injury, historical and forecasted epidemiology as…
Chronic Neuropathic Pain Market to Reach New Heights in Growth by 2032, DelveIns …
Chronic Neuropathic Pain Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | WEX Pharma, Lexicon Pharma, Bayer
The Chronic Neuropathic Pain market is…
Brain Hemorrhage Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approval …
(Albany, USA) DelveInsight's "Brain Hemorrhage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Brain Hemorrhage, historical and forecasted epidemiology as…
Smoking Cessation and Nicotine Addiction Treatment Market 2032: Clinical Trials, …
(Albany, USA) DelveInsight's "Smoking Cessation and Nicotine Addiction - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Smoking…
Dyskinesia Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Med …
(Albany, USA) DelveInsight's "Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Dyskinesia, historical and forecasted epidemiology as well as the…
Sulopenem Etzadroxil/Probenecid (orlynvah) by Iterum Therapeutics expected to ch …
Washington, D.C. - DelveInsight, a premier pharmaceutical market research firm, has launched its latest report, "Sulopenem Etzadroxil/Probenecid Market Size, Forecast, and Emerging Insight - 2032."…
Implanted Brain-Computer Interface (BCI) Devices Market Poised for Steady Growth …
[Albany, USA] - DelveInsight's Implanted Brain-Computer Interface (BCI) Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies' market…
Hemiplegia Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by Del …
DelveInsight's "Hemiplegia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hemiplegia, historical and forecasted epidemiology as well as the Hemiplegia…
Partial Paralysis Market Statistics Expected to Experience Major Growth by 2032, …
DelveInsight's "Partial Paralysis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Partial Paralysis, historical and forecasted epidemiology as well as…
Sturge-Weber Syndrome Market Revenue to Expand Significantly by 2032, States Del …
DelveInsight's "Sturge-Weber Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Sturge-Weber Syndrome, historical and forecasted epidemiology as well as…
Hemorrhagic Cystitis Market Growth to Accelerate in Forecast Period (2023-2032), …
DelveInsight's "Hemorrhagic Cystitis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hemorrhagic Cystitis, historical and forecasted epidemiology as well as…
Multiple Organ Dysfunction Syndrome Market to Show Remarkable Growth Trends from …
DelveInsight's "Multiple Organ Dysfunction Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Multiple Organ Dysfunction Syndrome, historical and forecasted…
Uveitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medica …
(New York, USA) DelveInsight's "Uveitis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Uveitis, historical and forecasted epidemiology as well as…
Contract Development and Manufacturing Organization Market is expected to grow a …
According to the latest report published by DelveInsight "Contract Development and Manufacturing Organization (CDMO) Market Insight," the global Contract Development and Manufacturing Organization market is…
Congenital Hyperinsulinism Market Poised for Significant Growth from 2024 to 203 …
The Congenital Hyperinsulinism market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Congenital…
Membranous Nephropathy Market Anticipated to Expand Rapidly During 2023-2032, Sa …
DelveInsight's "Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Membranous Nephropathy, historical and forecasted epidemiology as well as…
NK Cell Therapy Pipeline 2025: Key Developments, Emerging Therapies, and Clinica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Nk Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk…
Angelman Syndrome Pipeline and Clinical Trials Assessment, 2025 Updates: FDA App …
Angelman Syndrome pipeline constitutes 10+ key companies continuously working towards developing 10+ Angelman Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route…
Seizures Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medic …
(Albany, USA) DelveInsight's "Seizures Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Seizures, historical and forecasted epidemiology as well as the…
Spinal Muscular Atrophy Clinical Trials and Pipeline 2025: EMA, PDMA, FDA Approv …
(Albany, USA) "Spinal Muscular Atrophy Pipeline Insight, 2025′′ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the…
Spasticity Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Med …
(Albany, USA) DelveInsight's "Spasticity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Spasticity, historical and forecasted epidemiology as well as the…
Tardive Dyskinesia Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approv …
(Albany, USA) DelveInsight's "Tardive Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Tardive Dyskinesia, historical and forecasted epidemiology as well…
Restless Leg Syndrome Drugs Market 2032: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) DelveInsight's "Restless Leg Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Restless Leg Syndrome, historical and forecasted…
Primary Progressive Multiple Sclerosis Clinical Trials and Pipeline 2025: EMA, P …
(Albany, USA) "Primary Progressive Multiple Sclerosis Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects…
Post-traumatic Stress Disorder Clinical Trials and Pipeline 2025: EMA, PDMA, FDA …
(Albany, USA) DelveInsight's 'Post-traumatic Stress Disorder Pipeline Insight 2025' report provides comprehensive global coverage of available, marketed, and pipeline PTSD therapies in various stages of…
Postherpetic Neuralgia Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's "Postherpetic Neuralgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Postherpetic Neuralgia, historical and forecasted epidemiology as…
Peripheral Neuropathic Pain Treatment Market 2034: Clinical Trials, EMA, PDMA, F …
(Albany, USA) DelveInsight's "Peripheral Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Peripheral Neuropathic Pain, historical and forecasted…
Partial Seizure Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals …
(Albany, USA) DelveInsight's "Partial Seizure Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Partial Seizure, historical and forecasted epidemiology as well…
Cushing's Syndrome Pipeline 2025: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cushing's Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Cushing's Syndrome…
Chronic Traumatic Encephalopathy Pipeline 2025: MOA, ROA, FDA-Approved Drugs, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Traumatic Encephalopathy pipeline constitutes 4+ key companies continuously working towards developing 4+ Chronic…
Meibomian Gland Dysfunction Pipeline 2025: In-depth Clinical Trials Analysis and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Meibomian Gland Dysfunction pipeline constitutes 4+ key companies continuously working towards developing 4+ Meibomian…
Lupus Nephritis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lupus Nephritis pipeline constitutes 35+ key companies continuously working towards developing 40+ Lupus Nephritis…
Cough in Idiopathic Pulmonary Pipeline 2025: FDA Updates, Therapy Innovations, a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cough in Idiopathic Pulmonary Fibrosis pipeline constitutes 5+ key companies continuously working towards developing…
Hyperuricemia Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MO …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hyperuricemia pipeline constitutes 12+ key companies continuously working towards developing 15+ Hyperuricemia treatment therapies,…
Stargardt Disease Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Stargardt Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Stargardt Disease…
Diabetic Neuropathic Pain Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Neuropathic Pain pipeline constitutes 10+ key companies continuously working towards developing 12+ Diabetic…
Diabetic Macular Edema Pipeline 2025: Therapies Under Investigation, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Macular Edema pipeline constitutes key companies continuously working towards developing Diabetic Macular Edema…
Acute Myeloid Leukemia Pipeline 2025: MOA and ROA Insights, Clinical Trials Stat …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Myeloid Leukemia pipeline constitutes 110+ key companies continuously working towards developing 120+ Acute…
Vascular Dementia Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, …
(Albany, USA) DelveInsight's 'Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as…
Acute Ischemic Stroke Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Acute Ischemic Stroke, historical and forecasted…
Alzheimer's Disease Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Appro …
(Albany, USA) DelveInsight's "Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Alzheimer's Disease, historical and forecasted epidemiology as well…
Amyotrophic Lateral Sclerosis Market Forecast 2034: FDA, EMA, PDMA Approvals, Cl …
(Albany, USA) DelveInsight's "Amyotrophic Lateral Sclerosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Amyotrophic Lateral Sclerosis, historical and forecasted epidemiology…
Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market 2032: Clinical …
(Albany, USA) DelveInsight's "Attention Deficit Hyperactivity Disorder Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Attention Deficit Hyperactivity Disorder, historical…
Fibromyalgia Treatment Market 2034: Clinical Trials, FDA, EMA, PDMA Approvals, M …
(Albany, USA) DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as…
Migraine Treatment Market 2034: Clinical Trials, FDA, EMA, PDMA Approvals, Medic …
(Albany, USA) DelveInsight's "Migraine Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Migraine, historical and forecasted epidemiology as well as…
